Evidence map›Paper›PMID 37998401›Full record

ArticleCells2023

Oral Administration of Rhamnan Sulfate from

Masahiro Terasawa, Liqing Zang, Keiichi Hiramoto, Yasuhito Shimada, Mari Mitsunaka, Ryota Uchida, Kaoru Nishiura, Koichi Matsuda, Norihiro Nishimura, Koji Suzuki

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Masahiro TerasawaKonan Chemical Manufacturing Co., Ltd., Kitagomizuka, Kusu-cho, Yokkaichi 510-0103, Japan.ORCID 0000-0003-1250-1569
Liqing ZangGraduate School of Regional Innovation Studies, Mie University, Tsu 514-8507, Japan.ORCID 0000-0001-6936-795X
Keiichi HiramotoFaculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Minamitamagaki-cho, Suzuka 513-8670, Japan.
Yasuhito ShimadaDepartment of Integrative Pharmacology, Mie University Graduate School of Medicine, Tsu 514-8507, Japan.ORCID 0000-0002-4111-8262
Mari MitsunakaDepartment of Integrative Pharmacology, Mie University Graduate School of Medicine, Tsu 514-8507, Japan.
Ryota UchidaKonan Chemical Manufacturing Co., Ltd., Kitagomizuka, Kusu-cho, Yokkaichi 510-0103, Japan.
Kaoru NishiuraKonan Chemical Manufacturing Co., Ltd., Kitagomizuka, Kusu-cho, Yokkaichi 510-0103, Japan.
Koichi MatsudaKonan Chemical Manufacturing Co., Ltd., Kitagomizuka, Kusu-cho, Yokkaichi 510-0103, Japan.
Norihiro NishimuraGraduate School of Regional Innovation Studies, Mie University, Tsu 514-8507, Japan.ORCID 0000-0001-9866-4013
Koji SuzukiFaculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Minamitamagaki-cho, Suzuka 513-8670, Japan.
Mie University · JPSuzuka University of Medical Science · JPNippon Chemical Industrial (Japan) · JP

Funding

Japan Society for the Promotion of Science 18H05299Japan Society for the Promotion of Science 19K08850Japan Society for the Promotion of Science 22K08489
6 · The paper itself

Abstract

Oral administration of rhamnan sulfate (RS), derived from the seaweed

Indexed as

AtherosclerosisChlorophytaAdministration, OralAnimalsApolipoproteins EDeoxy SugarsDiet, High-FatEdible SeaweedsFemaleInflammationMannansMiceReceptors, Cell SurfaceRNA, MessengerSulfatesApolipoproteins EDeoxy SugarsMannansReceptors, Cell SurfacerhamnanRNA, MessengerRobo4 protein, mouseSulfatesApoE-deficient mouseatherosclerosisMonostroma nitidumrhamnan sulfate

Identifiers

PMID37998401
PMCPMC10670814
OpenAlexW4388834511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.